Added to YB: 2026-08-05
Pitch date: 2026-05-28
PNV.AX [bullish]
PolyNovo Limited
-23.51%
current return
Author Info
No bio for this author
Company Info
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China.
Market Cap
AUD 663.2M
Pitch Price
AUD 1.25
Price Target
2.53 (+165%)
Dividend
N/A
EV/EBITDA
38.47
P/E
91.43
EV/Sales
4.31
Sector
Health Care Equipment and Supplies
Category
growth
PolyNovo Limited - $PNV.AX
PNV.AX: Aussie med-device, NovoSorb biodegradable scaffold displacing 60yr legacy biologics in wound care. 94%+ GM, never lost a customer, 106k+ patients/46 countries. New CMS flat $127/cm² reimbursement flips economics vs pricey peers (Organogenesis/MiMedx guiding declines). New CEO ex-Dentsply resolves governance mess. 14% short interest (factor-driven, no fundamental shorts), COVID precedent saw 150% rally on unwind. FY26 rev ~A$155M, 50% margins at scale (vs <10% now) = A$77.5M op profit on <A$700M EV = <9x potential earnings. 25x multiple = ~150% upside/3yrs. Catalysts: US PMA, squeeze, revenue reaccel, takeover.
Read full article (7 min)